Put Options Transactions Made in Q4 2024 in Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC) during Q4 2024. The information is specifically focused on institutions that hold put options of Revance Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2025
Q4 2024
|
Meteora Capital, LLC
Boca Raton, FL |
BUY
|
PUT |
2.87MNew |
N/A
|
2.87M
$7.37M
|
|
Feb 14, 2025
Q4 2024
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
PUT |
1.87MNew |
N/A
|
1.87M
$4.79M
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
PUT |
361K+ 775.11% |
N/A
|
408K
$1.05M
|
|
Feb 14, 2025
Q4 2024
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
PUT |
195KNew |
N/A
|
195K
$500K
|
|
Feb 14, 2025
Q4 2024
|
Lmr Partners LLP
London, X0 |
BUY
|
PUT |
100KNew |
N/A
|
100K
$257K
|
|
Feb 14, 2025
Q4 2024
|
Css LLC
Chicago, IL |
SELL
|
PUT |
-4.3K- 10.41% |
N/A
|
37K
$95.1K
|